CMCSA
44
-2
BWA
53
-7
BMY
76
2
AZO
42
-3
BAC
77
5
ALL
56
2
BAX
38
-12
C
82
3
BIIB
50
4
AMG
77
3
CMI
71
2
AIG
77
2
CMS
60
-2
APA
53
5
AEP
61
-3
D
41
-4
ACN
56
2
AIZ
78
2
CNX
49
3
CMA
70
5
CMCSA
44
-2
BWA
53
-7
BMY
76
2
AZO
42
-3
BAC
77
5
ALL
56
2
BAX
38
-12
C
82
3
BIIB
50
4
AMG
77
3
CMI
71
2
AIG
77
2
CMS
60
-2
APA
53
5
AEP
61
-3
D
41
-4
ACN
56
2
AIZ
78
2
CNX
49
3
CMA
70
5
Financhill
Back

Direxion Daily S&P Biotech Bear 3X Shares Vs. Ultragenyx Pharmaceutical, Inc. Industry Stock Comparison

Sell
30

LABD
Direxion Daily S&P Biotech Bear 3X Shares

Last Price:
$20.84
Seasonality Move:
-0.37%
Sell
18

RARE
Ultragenyx Pharmaceutical, Inc.

Last Price:
$33.50
Seasonality Move:
-0.96%
Sell
30
Direxion Daily S&P Biotech Bear 3X Shares (LABD) is a Sell

Is Direxion Daily S&P Biotech Bear 3X Shares a Buy, Sell or Hold?

  • The current Direxion Daily S&P Biotech Bear 3X Shares [LABD] share price is $20.82. The Score for LABD is 30, which is 40% below its historic median score of 50, and infers higher risk than normal.
  • LABD is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
18
Ultragenyx Pharmaceutical, Inc. (RARE) is a Sell

Is Ultragenyx Pharmaceutical, Inc. a Buy, Sell or Hold?

  • The current Ultragenyx Pharmaceutical, Inc. [RARE] share price is $33.50. The Score for RARE is 18, which is 64% below its historic median score of 50, and infers higher risk than normal.
  • RARE is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing an extreme reading that indicates risk could be especially high.

LABD Stock Price Chart

What is Direxion Daily S&P Biotech Bear 3X Shares's stock price today?

  • The Direxion Daily S&P Biotech Bear 3X Shares share price today is $20.82
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and LABD is experiencing selling pressure, which indicates risk of future bearish movement.

RARE Stock Price Chart

What is Ultragenyx Pharmaceutical, Inc.'s stock price today?

  • The Ultragenyx Pharmaceutical, Inc. share price today is $33.50
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and RARE is experiencing slight buying pressure.

LABD Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -1.69 Sell
Relative Strength Index (14 RSI): 36.36 Sell
Chaikin Money Flow: -2264299 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): ( - ) Buy
Bollinger Bands (100): ( - ) Buy

RARE Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 6.24 Buy
Relative Strength Index (14 RSI): 45.54 Sell
Chaikin Money Flow: 579058 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (32.65 - 35.95) Sell
Bollinger Bands (100): (29.19 - 34.19) Buy

LABD Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 21.55 Sell
20-day SMA: 21.93 Sell
50-day SMA: 26.81 Sell
200-day SMA: 60.71 Sell
8-day EMA: 21.68 Sell
20-day EMA: 22.71 Sell
50-day EMA: 28 Sell
200-day EMA: 50.75 Sell

RARE Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 34.82 Sell
20-day SMA: 34.8 Sell
50-day SMA: 33.74 Sell
200-day SMA: 33.57 Sell
8-day EMA: 17.59 Buy
20-day EMA: 8.61 Buy
50-day EMA: 3.75 Buy
200-day EMA: 0.98 Buy

Direxion Daily S&P Biotech Bear 3X Shares Earnings Growth & LABD Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Ultragenyx Pharmaceutical, Inc. Earnings Growth & RARE Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.20 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.39 per share, and an increase next year of $1.31 per share.

Direxion Daily S&P Biotech Bear 3X Shares Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Ultragenyx Pharmaceutical, Inc. Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):